Free Trial

Cabot Co. (NYSE:CBT) Shares Acquired by Envestnet Asset Management Inc.

Cabot logo with Basic Materials background

Envestnet Asset Management Inc. raised its holdings in Cabot Co. (NYSE:CBT - Free Report) by 2.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 335,261 shares of the specialty chemicals company's stock after purchasing an additional 8,044 shares during the period. Envestnet Asset Management Inc. owned about 0.62% of Cabot worth $30,613,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Dynamic Technology Lab Private Ltd raised its position in Cabot by 153.4% during the fourth quarter. Dynamic Technology Lab Private Ltd now owns 23,870 shares of the specialty chemicals company's stock worth $2,179,000 after acquiring an additional 14,449 shares during the period. Trexquant Investment LP boosted its holdings in Cabot by 99.0% in the 4th quarter. Trexquant Investment LP now owns 109,423 shares of the specialty chemicals company's stock worth $9,991,000 after buying an additional 54,429 shares during the last quarter. O Shaughnessy Asset Management LLC raised its holdings in shares of Cabot by 13.0% during the fourth quarter. O Shaughnessy Asset Management LLC now owns 28,091 shares of the specialty chemicals company's stock valued at $2,565,000 after acquiring an additional 3,235 shares during the last quarter. Brandywine Global Investment Management LLC lifted its position in shares of Cabot by 149.7% in the fourth quarter. Brandywine Global Investment Management LLC now owns 42,651 shares of the specialty chemicals company's stock valued at $3,894,000 after acquiring an additional 25,572 shares in the last quarter. Finally, Dorsey Wright & Associates purchased a new stake in shares of Cabot during the fourth quarter worth approximately $3,201,000. 93.18% of the stock is owned by institutional investors and hedge funds.

Cabot Trading Up 0.1 %

Shares of Cabot stock traded up $0.08 during trading hours on Friday, hitting $78.40. The company's stock had a trading volume of 338,411 shares, compared to its average volume of 387,265. The stock has a market cap of $4.25 billion, a price-to-earnings ratio of 10.41, a P/E/G ratio of 0.74 and a beta of 1.04. Cabot Co. has a twelve month low of $73.63 and a twelve month high of $117.46. The firm has a fifty day moving average of $82.86 and a 200-day moving average of $95.12. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.29 and a current ratio of 2.00.

Cabot (NYSE:CBT - Get Free Report) last released its quarterly earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 EPS for the quarter, topping the consensus estimate of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. Research analysts forecast that Cabot Co. will post 7.57 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on CBT. StockNews.com raised shares of Cabot from a "hold" rating to a "buy" rating in a research note on Thursday. JPMorgan Chase & Co. dropped their price target on Cabot from $105.00 to $85.00 and set an "underweight" rating for the company in a research report on Friday, February 21st. UBS Group lowered their price objective on Cabot from $93.00 to $83.00 and set a "neutral" rating on the stock in a research note on Monday, April 7th. Finally, Mizuho cut their target price on Cabot from $122.00 to $110.00 and set an "outperform" rating for the company in a research note on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $93.25.

Check Out Our Latest Analysis on CBT

Cabot Company Profile

(Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

See Also

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Should You Invest $1,000 in Cabot Right Now?

Before you consider Cabot, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.

While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines